A Phase 1, Open-Label, Two-Arm, Parallel-Group, Pharmacokinetic Study on Plasma Clearance of Vasopressin in Healthy Volunteers
Latest Information Update: 20 May 2021
At a glance
- Drugs Vasopressin (Primary)
- Indications Hypotension
- Focus Pharmacokinetics
- Sponsors Endo Pharmaceuticals
Most Recent Events
- 17 May 2021 The study protocol amended to change timelines of primary endpoints from 8 days to 15 days.
- 12 Jan 2021 Status changed from recruiting to completed.
- 25 Sep 2020 Planned End Date changed from 1 Sep 2020 to 1 Nov 2020.